Loading organizations...
Loading organizations...
Key people at Nolan Capital.
Key people at Nolan Capital.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 9, 2023 | Palvella Therapeutics | $37.7M Series D | Gore Range Capital, Tadd S. Wessel | Agent Capital, BioAdvance, BVF Partners, Samsara BioCapital |
| Apr 1, 2021 | Jaguar Gene Therapy | $140.0M Series B | Deerfield Management, Andrew Adams | ARCH Venture Partners, Sofinnova Investments, Third Rock Ventures, Venrock, Heather Preston, Goldman Sachs, Sean Nolan |
| Jul 1, 2020 | Encoded Therapeutics | $140.0M Series D | GV | Menlo Ventures, Anne Wojcicki, ARCH Venture Partners, Boxer Capital, Farallon Capital Management, HBM Genomics, Illumina Ventures, Matrix Capital Management, Menlo Ventures, Meritech Capital Partners, Perceptive Advisors, RTW Investments, SoftBank |
| May 1, 2020 | Palvella Therapeutics | $45.0M Series C | — | Samsara BioCapital, Adams Street Partners, Agent Capital, BioAdvance, BVF Partners, Scott Morenstein, Ligand Pharmaceuticals, Sean Nolan, Opaleye Management |
| Apr 29, 2020 | Taysha Gene Therapies | $30.0M Seed | Sean Nolan, Paul Manning | — |
